NOTCH1 and lung cancer: The overexpression of Notch1 increases the resistance of lung cancers to cisplatin and paclitaxel [14], the resistance of breast cancers to melphalan and mitoxantrone [15] and the resistance of cervical cancers to doxorubicin [16].